Back

Divergent electrophysiologic safety profile of dapagliflozin and empagliflozin in a whole-heart model

27 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Mechanisms of atrial and ventricular arrhythmias Arrhythmias ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)

7 More presentations in this session

Presentation thumbnail
Loss-of-function variants in founder population highlight atrial myopathy as susceptibility to atrial fibrillation
Doctor C. Paludan-Muller (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Plasma miR-451a predicts atrial fibrillation recurrence after pulmonary vein ablation
Doctor M. Cebro Marquez (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Elevated thyroid-stimulating hormone (TSH) is associated with atrial fibrillation and directly modulates electrophysiological properties of atrial cardiomyocytes
Doctor A. Rahm (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Heterotypic Cx43/Cx45 gap junction channel conductance depends on pulse rate and could rescue from arrhythmogenic activity in cardiac tissue
Doctor K. Maciunas (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Radiation-induced electrophysiological remodelling in neonatal rat ventricular cardiomyocytes
Miss H. Gampp (Heidelberg, DE)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms of atrial and ventricular arrhythmias

The Event

Event poster

ESC Congress 2022

27 August 2022 16:15 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources